Clinical Trial Update: Uterovaginal Plexus Block With Articaine for Intrauterine Device Placement Patients Who Are Indicated for the Use of Copper IUD as a Contraceptive Method Will be Invited to Participate in This Research. [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update inviting participants for uterovaginal plexus block with articaine during copper IUD placement.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Contraception
• Iud

Drugs mentioned

• Articaine (articaine)

Snippet

Sponsor: Universidade do Vale do Sapucai | Conditions: Contraception, IUD | Phase 4 | Status: UNKNOWN